CDKN2A and Miyoshi myopathy: These epimutations play an important role in disrupting critical regulatory networks in MM, such as the Wnt/β-catenin, JAK/STAT, Cyclin/CDK/Rb, and DAPK/p14ARF/p53 pathway amongst others (30).